Furthermore, it is demonstrated that six2 can increase the expression of CYP4Z1 and CYP4Z2P and also activate ceRNET_CC by binding to their promoters, which in turn promotes the stemness of breast cancer cells. Here, CYP4Z2P is linked to breast carcinoma.